SynthesisFrontiers in immunology2026
Risk of cancer in periodontal disease: an umbrella review of meta-analyses.
Synthesis in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to summarize and appraise the credibility of existing epidemiological evidence on the association between periodontal diseases (PDs) and the risk of site-specific cancers. Methods: PubMed, Embase, and Cochrane Library were searched from inception to June 2026. Meta-analyses of observational studies investigating PDs and cancer risk were included. Each association was classified into five levels according to a predefined criterion, which included statistical significance, heterogeneity, sample size, and bias assessment. AMSTAR 2 was used to evaluate the quality of studies. Corrected covered area and the author's own meta-analysis were performed to ensure a rigorous methodology. Results: In total, 66 associations from 38 meta-analyses investigating 14 cancer types were appraised, including head and neck cancer (HNC), oral, lung, breast, esophageal, gastric, pancreatic, liver, colorectal, bladder, kidney, prostate, melanoma, and hematopoietic and lymphatic cancers. Among 23 main associations, highly suggestive evidence was identified in associations between PDs (odds ratio [OR], 2.42; 95% confidence interval [CI], 1.85-3.17) in HNC, and PDs in oral cancer (OR, 2.94; 95% CI, 2.13-4.07). Another seven associations were recommended as suggestive evidence (class III). Fourteen associations were classified as weak (class IV) or showing no significant evidence (class V). Conclusion: Associations between PDs and site-specific cancers demonstrated varying levels of evidence. This analysis highlighted strong correlations in HNC and oral cancer, while failing to show credible evidence for the remaining 12 cancers. Overall, our study yielded novel insights into oral health interventions, calling for the incorporation of periodontal health into public health policy. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42024585375, identifier CRD42024585375.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.